Retail Trade
Welcia Holdings Co., Ltd.
In the news
- New China virus spurs 24-hour output of surgical masks in Japan Jan 18, 2020
- Japanese drugstore chains discuss merger to become top player Jun 2, 2019
- Longer hours score record profit for drugstore Welcia Apr 3, 2018
- Japan drugstore stocks slide as growing expenses spook investors Mar 2, 2018
- Japan's big retailers mark first net profit growth in 3 years Jan 12, 2018 See more articles on Welcia Holdings Co., Ltd.
Business Summary
Welcia Holdings Co., Ltd. engages in the management of its subsidiaries and group companies which are in the pharmaceutical business. Its core business deals with the operation of drug store chains which offer prescription drugs and pharmaceuticals, sanitation and nursing care items, health food products, baby supplies, cosmetics, and household sundries. The company was founded on September 1, 2008 and is headquartered in Tokyo, Japan.
Financial Highlights
| Feb 2020 | JPY | USD |
| Revenue | 868,280M | 7,965.15M |
| Gross Profit | 252,061M | 2,312.27M |
| Operating income | 37,803M | 346.78M |
| Income before tax | 35,936M | 329.65M |
| Net income | 22,802M | 209.17M |
| EBITDA | 53,466M | 490.46M |
| Diluted EPS | 218.24 | 2.00 |
| Dividends Per Share | 50 | 0.45 |
| Total Assets | 390,006M | 3,615.68M |
| Total liabilities | 227,584M | 2,109.89M |
| Total equity | 161,925M | 1,501.18M |
| Operating cash flow | 70,156M | 643.57M |
| Currency in JPY | Currency in USD |
Historical Data
| Feb 2016 | Feb 2017 | Feb 2018 | Feb 2019 | Feb 2020 | |
| Revenue | 528,402M | 623,163M | 695,268M | 779,148M | 868,280M |
| Gross Profit | 139,902M | 172,155M | 196,958M | 222,431M | 252,061M |
| Operating income | 18,759M | 24,080M | 28,827M | 29,046M | 37,803M |
| Income before tax | 16,511M | 23,184M | 26,777M | 28,511M | 35,936M |
| Net income | 9,527M | 14,450M | 17,165M | 17,423M | 22,802M |
| EBITDA | 29,042M | 36,033M | 42,093M | 43,542M | 53,466M |
| Diluted EPS | 97.62 | 138.78 | 164.77 | 167.07 | 218.24 |
| Dividends Per Share | 21 | 28.50 | 37 | 42 | 50 |
| Total Assets | 228,227M | 248,883M | 292,238M | 327,426M | 390,006M |
| Total liabilities | 124,448M | 132,648M | 161,751M | 183,474M | 227,584M |
| Total equity | 103,771M | 116,227M | 129,732M | 143,287M | 161,925M |
| Operating cash flow | 15,031M | 33,303M | 35,902M | 34,872M | 70,156M |
| Feb 2016 | Feb 2017 | Feb 2018 | Feb 2019 | Feb 2020 | |
| Revenue | 4,376.83M | 5,755.66M | 6,240.85M | 7,052.42M | 7,965.15M |
| Gross Profit | 1,158.83M | 1,590.06M | 1,767.93M | 2,013.32M | 2,312.27M |
| Operating income | 155.38M | 222.40M | 258.75M | 262.90M | 346.78M |
| Income before tax | 136.76M | 214.13M | 240.35M | 258.06M | 329.65M |
| Net income | 78.91M | 133.46M | 154.07M | 157.70M | 209.17M |
| EBITDA | 240.55M | 332.80M | 377.83M | 394.11M | 490.46M |
| Diluted EPS | 0.80 | 1.28 | 1.47 | 1.51 | 2.00 |
| Dividends Per Share | 0.17 | 0.26 | 0.33 | 0.38 | 0.45 |
| Total Assets | 2,021.94M | 2,224.45M | 2,738.74M | 2,941.30M | 3,615.68M |
| Total liabilities | 1,102.52M | 1,185.57M | 1,515.87M | 1,648.16M | 2,109.89M |
| Total equity | 919.34M | 1,038.80M | 1,215.80M | 1,287.16M | 1,501.18M |
| Operating cash flow | 124.50M | 307.59M | 322.26M | 315.64M | 643.57M |
Valuation Measures
| Feb 2020 | |
| PER | 29.75 |
| ROA | 6.35% |
| ROE | 14.94% |
| Operating margin | 4.35% |
| Profit margin | 2.62% |
Key executives
- President, COO & Representative Director: Tadahisa Matsumoto
- Chief Financial Officer & Senior Managing Director: Norimasa Sato
- Director & Executive Officer: Takashi Abe
- MD, Head-Public Relations, Legal, Operations & IR: Juichi Nakamura
- Auditor: Toshio Miyamoto
Shareholders
- AEON Co., Ltd. (50.5%)
- Asset Management One Co., Ltd. (3.5%)
- Fidelity Management & Research Co. LLC (2.2%)
- Nomura Asset Management Co., Ltd. (1.6%)
- TSURUHA Holdings, Inc. (1.5%)
- Welcia Holdings Employee Stockownership Plan (1.5%)
- The Vanguard Group, Inc. (1.4%)
- BlackRock Fund Advisors (1.2%)
- Fidelity (Canada) Asset Management ULC (1.1%)
- T. Rowe Price Associates, Inc. (Investment Management) (0.8%)
Contact Details
- Website:http://www.welcia.co.jp
- Address: Welcia Building, 2-2-15 Sotokanda, Tokyo, 101-0021, Japan
- Phone: +81.3.5207.5878
Related Companies
- Neo Pharma, Inc.
- Kusuri No Marue KK
- Masaya KK
- IPPONDO Co., Ltd.
- Welcia Holdings Board Incentive Plan
- Welcia Holdings Employee Incentive Plan 2
- Welcia Holdings Employee Incentive Plan 1
- Lianhua Meiriling Commercial (Shanghai) Co., Ltd.
- Nagata Yakkyoku KK
- Kanamitsu Yakuhin KK
- Yodoya KK
- Marudai Sakurai Pharmacy Ltd.
- Takiya Co., Ltd.
- Welcia Holdings Employee Stockownership Plan
- Shimizu Drug KK
- Welcia Yakkyoku Co., Ltd.
Competitors
- TSURUHA Holdings, Inc.
- KUSURI NO AOKI HOLDINGS CO.,LTD.
- Sundrug Co., Ltd.
- SATUDORA HOLDINGS CO., LTD.
- cocokara fine Inc.
Copyright © 2020 FactSet Research Systems Inc. All rights reserved.
Last Updated on 6 Aug, 2020